Showing results (271-280 of 413) with videos related to

Sort By:
Pageof 42
Medicine|August 30, 2019
Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patientsMin Soo Cho, HonSoul Kim, Yoon Dae Han, et al.
BMC Gastroenterology|March 29, 2022
Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn's disease in patients with prior failure of anti-tumour necrosis factor treatmentHye Kyung Hyun, Hyun-Soo Zhang, Jongwook Yu, et al.
Yonsei Medical Journal|October 23, 2024
Development and Assessment of a Novel Ulcerative Colitis-Specific Quality of Life Questionnaire: A Prospective, Multi-Institutional StudyJihye Park, Hyun-Soo Zhang, Chung Mo Nam, et al.
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|October 19, 2006
[The trend of eradication rates of first-line triple therapy for Helicobacter pylori infection: single center experience for recent eight years]You Sik Choi, Jae Hee Cheon, Jong Yeul Lee, et al.
Medicine|June 10, 2016
The Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel DiseaseHye Won Lee, Sook Hee Chung, Chang Mo Moon, et al.
Digestive Diseases and Sciences|June 10, 2009
The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitisJin Ha Lee, Jae Hee Cheon, Eun Soo Kim, et al.
Oncotarget|December 17, 2014
Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironment via myeloid-derived suppressor cellsBo-Ra Lee, Sun-Young Chang, Eun-Hye Hong, et al.
Journal of Gastroenterology and Hepatology|March 10, 2019
ZNF133 is associated with infliximab responsiveness in patients with inflammatory bowel diseasesEun Suk Jung, Ko-Woon Choi, Seung Won Kim, et al.
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|February 24, 2005
[Trial of moxifloxacin-containing triple therapy after initial and second-line treatment failures for Helicobacter pylori infection]Jae Hee Cheon, Nayoung Kim, Dong Ho Lee, et al.
European Journal of Gastroenterology & Hepatology|September 11, 2018
Compound heterozygous mutations in IL10RA combined with a complement factor properdin mutation in infantile-onset inflammatory bowel diseaseEun Suk Jung, Britt-Sabina Petersen, Gabriele Mayr, et al.
Pageof 42